Literature DB >> 22452361

Heat-labile enterotoxin-induced activation of NF-κB and MAPK pathways in intestinal epithelial cells impacts enterotoxigenic Escherichia coli (ETEC) adherence.

Xiaogang Wang1, Xiaofei Gao, Philip R Hardwidge.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) causes human morbidity and mortality in developing nations and is an emerging threat to food safety in developed nations. The ETEC heat-labile enterotoxin (LT) not only causes diarrheal disease by deregulating host adenylate cyclase, but also enhances ETEC adherence to intestinal epithelial cells. The mechanism governing this LT pro-adherence phenotype is unclear. Here we investigated intestinal epithelial cell signal transduction pathways activated by ETEC and quantified the relative importance of these host pathways to LT-induced ETEC adherence. We show that ETEC activates both NF-κB and mitogen-activated protein kinase signalling pathways through mechanisms that are primarily dependent upon LT. LT-induced NF-κB activation depends upon the cAMP-dependent activation of the Ras-like GTPase Rap1 but is independent of protein kinase A (PKA). By using inhibitors of these pathways, we demonstrate that inhibiting the p38 mitogen-activated protein kinase prevents LT from increasing ETEC adherence. By contrast, the LT pro-adherence phenotype appears unrelated to both LT-induced Rap1 activity and to subsequent NF-κB activation. We speculate that LT may alter host signal transduction to induce the presentation of ligands for ETEC adhesins in such a way that promotes ETEC adherence. Our findings provide insight into previously unexplored functions of LT and their relative importance to ETEC virulence.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452361      PMCID: PMC3391543          DOI: 10.1111/j.1462-5822.2012.01793.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  35 in total

1.  Epidemic diarrhea due to enterotoxigenic Escherichia coli.

Authors:  Mark E Beatty; Penny M Adcock; Stephanie W Smith; Kyran Quinlan; Laurie A Kamimoto; Samantha Y Rowe; Karen Scott; Craig Conover; Thomas Varchmin; Cheryl A Bopp; Kathy D Greene; Bill Bibb; Laurence Slutsker; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2005-12-27       Impact factor: 9.079

2.  BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.

Authors:  A Jin; T Kurosu; K Tsuji; D Mizuchi; A Arai; H Fujita; M Hattori; N Minato; O Miura
Journal:  Oncogene       Date:  2006-03-06       Impact factor: 9.867

Review 3.  Molecular mechanisms of enterotoxigenic Escherichia coli infection.

Authors:  James M Fleckenstein; Philip R Hardwidge; George P Munson; David A Rasko; Halvor Sommerfelt; Hans Steinsland
Journal:  Microbes Infect       Date:  2009-10-31       Impact factor: 2.700

4.  Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum.

Authors:  W A Tompkins; A M Watrach; J D Schmale; R M Schultz; J A Harris
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

Review 5.  Signal transduction and gene regulation: the nuclear response to cAMP.

Authors:  E Lalli; P Sassone-Corsi
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

Review 6.  LPS induction of gene expression in human monocytes.

Authors:  M Guha; N Mackman
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

7.  The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: Gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages.

Authors:  Uma K Misra; Steven Kaczowka; Salvatore V Pizzo
Journal:  Cell Signal       Date:  2008-04-15       Impact factor: 4.315

8.  cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.

Authors:  M R Vossler; H Yao; R D York; M G Pan; C S Rim; P J Stork
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

Review 9.  Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli.

Authors:  Susan M Turner; Anthony Scott-Tucker; Lisa M Cooper; Ian R Henderson
Journal:  FEMS Microbiol Lett       Date:  2006-10       Impact factor: 2.742

10.  Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells.

Authors:  Amber M Johnson; Radhey S Kaushik; David H Francis; James M Fleckenstein; Philip R Hardwidge
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

View more
  21 in total

1.  Enterotoxigenic Escherichia coli prevents host NF-κB activation by targeting IκBα polyubiquitination.

Authors:  Xiaogang Wang; Philip R Hardwidge
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

2.  Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production.

Authors:  Xiaofei Gao; Thanh H Pham; Leigh Ann Feuerbacher; Kangming Chen; Michael P Hays; Gyanendra Singh; Christian Rueter; Ramon Hurtado-Guerrero; Philip R Hardwidge
Journal:  J Biol Chem       Date:  2016-07-07       Impact factor: 5.157

3.  Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans.

Authors:  William E Yang; Sunil Suchindran; Bradly P Nicholson; Micah T McClain; Thomas Burke; Geoffrey S Ginsburg; Clayton D Harro; Subhra Chakraborty; David A Sack; Christopher W Woods; Ephraim L Tsalik
Journal:  J Infect Dis       Date:  2016-01-18       Impact factor: 5.226

4.  CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli.

Authors:  Alaullah Sheikh; Brunda Tumala; Tim J Vickers; David Alvarado; Matthew A Ciorba; Taufiqur Rahman Bhuiyan; Firdausi Qadri; Bernhard B Singer; James M Fleckenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

5.  Bacillus licheniformis PF9 improves barrier function and alleviates inflammatory responses against enterotoxigenic Escherichia coli F4 infection in the porcine intestinal epithelial cells.

Authors:  Qiao Li; Linyan Li; Yanhong Chen; Changning Yu; Paula Azevedo; Joshua Gong; Chengbo Yang
Journal:  J Anim Sci Biotechnol       Date:  2022-07-08

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway.

Authors:  Ganapathy A Subramenium; Subrata Sabui; Jonathan S Marchant; Hamid M Said; Veedamali S Subramanian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

8.  Early supplementation with Lactobacillus plantarum in liquid diet modulates intestinal innate immunity through toll-like receptor 4-mediated mitogen-activated protein kinase signaling pathways in young piglets challenged with Escherichia coli K88.

Authors:  Kuanmin M Yang; Cui Zhu; Li Wang; Shuting T Cao; Xuefen F Yang; Kaiguo G Gao; Zongyong Y Jiang
Journal:  J Anim Sci       Date:  2021-06-01       Impact factor: 3.159

9.  Electron Acceptors Induce Secretion of Enterotoxigenic Escherichia coli Heat-Labile Enterotoxin under Anaerobic Conditions through Promotion of GspD Assembly.

Authors:  Xi Lu; Enqing Fu; Yonghong Xie; Faguang Jin
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 10.  Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor.

Authors:  Catherine H Schein; Deliang Chen; Lili Ma; John J Kanalas; Jian Gao; Maria Estrella Jimenez; Laurie E Sower; Mary A Walter; Scott R Gilbertson; Johnny W Peterson
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.